Aurinia Pharmaceuticals (AUPH) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Aurinia Pharmaceuticals, a leader in autoimmune disease therapies, will unveil its second-quarter financial and operational results on August 1, 2024. The announcement will be followed by a conference call and webcast led by the management team to discuss the outcomes and provide business updates. This pivotal update is expected to draw significant attention from investors and market watchers.
For further insights into AUPH stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue